Epidermal growth factor receptor targeting in cancer
J Mendelsohn, J Baselga - Seminars in oncology, 2006 - Elsevier
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase of the ErbB family
that is abnormally activated in many epithelial tumors. Several mechanisms lead to the …
that is abnormally activated in many epithelial tumors. Several mechanisms lead to the …
Critical update and emerging trends in epidermal growth factor receptor targeting in cancer
J Baselga, CL Arteaga - Journal of Clinical Oncology, 2005 - ascopubs.org
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase of the ErbB
receptor family that is abnormally activated in many epithelial tumors. The aberrant …
receptor family that is abnormally activated in many epithelial tumors. The aberrant …
Improved prediction of prostate cancer recurrence through systems pathology
C Cordon-Cardo, A Kotsianti, DA Verbel… - The Journal of …, 2007 - Am Soc Clin Investig
We have developed an integrated, multidisciplinary methodology, termed systems
pathology, to generate highly accurate predictive tools for complex diseases, using prostate …
pathology, to generate highly accurate predictive tools for complex diseases, using prostate …
The Future of Predictive Testing.
MJ Donovan, C Cordon-Cardo - Applied Clinical Trials, 2005 - search.ebscohost.com
The article reports on the need for the biopharmaceutical industry to develop companion
cancer diagnostics in parallel with the targeted therapies in order for the industry to develop …
cancer diagnostics in parallel with the targeted therapies in order for the industry to develop …